0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pet Veterinary Drug Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-25L3505
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global Pet Veterinary Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Pet Veterinary Drug Market Insights, Forecast to 2030

Code: QYRE-Auto-25L3505
Report
December 2024
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pet Veterinary Drug Market Size

The global Pet Veterinary Drug market is projected to grow from US$ 9099 million in 2024 to US$ 12120 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.9% during the forecast period.

Pet Veterinary Drug Market

Pet Veterinary Drug Market

Pet Veterinary Drug refers to a drug used in the diagnosis, cure, mitigation, treatment or prevention of diseases in pets.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 47%.
Report Covers:
This report presents an overview of global market for Pet Veterinary Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pet Veterinary Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pet Veterinary Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pet Veterinary Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pet Veterinary Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pet Veterinary Drug sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Pet Veterinary Drug Market Report

Report Metric Details
Report Name Pet Veterinary Drug Market
Accounted market size in 2024 US$ 9099 million
Forecasted market size in 2030 US$ 12120 million
CAGR 4.9
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
  • Anti-Infectives
  • Anti-Inflammatory
  • Parasiticides
  • Analgesics
  • Sedatives
  • Others
Segment by Application
  • Veterinary Hospitals
  • Veterinary Clinics
  • Drug Stores
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer AG, Merck Animal Health, Elanco Animal Health Inc., Virbac Group, Ceva, Dechra Pharmaceuticals Plc, Vetoquinol, Orion Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Pet Veterinary Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Pet Veterinary Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Veterinary Drug sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Pet Veterinary Drug Market growing?

Ans: The Pet Veterinary Drug Market witnessing a CAGR of 4.9 during the forecast period 2025-2030.

What is the Pet Veterinary Drug Market size in 2030?

Ans: The Pet Veterinary Drug Market size in 2030 will be US$ 12120 million.

Who are the main players in the Pet Veterinary Drug Market report?

Ans: The main players in the Pet Veterinary Drug Market are Bayer AG, Merck Animal Health, Elanco Animal Health Inc., Virbac Group, Ceva, Dechra Pharmaceuticals Plc, Vetoquinol, Orion Corporation

What are the Application segmentation covered in the Pet Veterinary Drug Market report?

Ans: The Applications covered in the Pet Veterinary Drug Market report are Veterinary Hospitals, Veterinary Clinics, Drug Stores

What are the Type segmentation covered in the Pet Veterinary Drug Market report?

Ans: The Types covered in the Pet Veterinary Drug Market report are Anti-Infectives, Anti-Inflammatory, Parasiticides, Analgesics, Sedatives, Others

Recommended Reports

Veterinary Pharmaceuticals

Pet Health Products

Veterinary Equipment

1 Study Coverage
1.1 Pet Veterinary Drug Product Introduction
1.2 Market by Type
1.2.1 Global Pet Veterinary Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Anti-Infectives
1.2.3 Anti-Inflammatory
1.2.4 Parasiticides
1.2.5 Analgesics
1.2.6 Sedatives
1.2.7 Others
1.3 Market by Application
1.3.1 Global Pet Veterinary Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Drug Stores
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pet Veterinary Drug Sales Estimates and Forecasts 2019-2030
2.2 Global Pet Veterinary Drug Revenue by Region
2.2.1 Global Pet Veterinary Drug Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Pet Veterinary Drug Revenue by Region (2019-2024)
2.2.3 Global Pet Veterinary Drug Revenue by Region (2025-2030)
2.2.4 Global Pet Veterinary Drug Revenue Market Share by Region (2019-2030)
2.3 Global Pet Veterinary Drug Sales Estimates and Forecasts 2019-2030
2.4 Global Pet Veterinary Drug Sales by Region
2.4.1 Global Pet Veterinary Drug Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Pet Veterinary Drug Sales by Region (2019-2024)
2.4.3 Global Pet Veterinary Drug Sales by Region (2025-2030)
2.4.4 Global Pet Veterinary Drug Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pet Veterinary Drug Sales by Manufacturers
3.1.1 Global Pet Veterinary Drug Sales by Manufacturers (2019-2024)
3.1.2 Global Pet Veterinary Drug Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pet Veterinary Drug in 2023
3.2 Global Pet Veterinary Drug Revenue by Manufacturers
3.2.1 Global Pet Veterinary Drug Revenue by Manufacturers (2019-2024)
3.2.2 Global Pet Veterinary Drug Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pet Veterinary Drug Revenue in 2023
3.3 Global Key Players of Pet Veterinary Drug, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Pet Veterinary Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pet Veterinary Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pet Veterinary Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pet Veterinary Drug, Product Offered and Application
3.8 Global Key Manufacturers of Pet Veterinary Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pet Veterinary Drug Sales by Type
4.1.1 Global Pet Veterinary Drug Historical Sales by Type (2019-2024)
4.1.2 Global Pet Veterinary Drug Forecasted Sales by Type (2025-2030)
4.1.3 Global Pet Veterinary Drug Sales Market Share by Type (2019-2030)
4.2 Global Pet Veterinary Drug Revenue by Type
4.2.1 Global Pet Veterinary Drug Historical Revenue by Type (2019-2024)
4.2.2 Global Pet Veterinary Drug Forecasted Revenue by Type (2025-2030)
4.2.3 Global Pet Veterinary Drug Revenue Market Share by Type (2019-2030)
4.3 Global Pet Veterinary Drug Price by Type
4.3.1 Global Pet Veterinary Drug Price by Type (2019-2024)
4.3.2 Global Pet Veterinary Drug Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Pet Veterinary Drug Sales by Application
5.1.1 Global Pet Veterinary Drug Historical Sales by Application (2019-2024)
5.1.2 Global Pet Veterinary Drug Forecasted Sales by Application (2025-2030)
5.1.3 Global Pet Veterinary Drug Sales Market Share by Application (2019-2030)
5.2 Global Pet Veterinary Drug Revenue by Application
5.2.1 Global Pet Veterinary Drug Historical Revenue by Application (2019-2024)
5.2.2 Global Pet Veterinary Drug Forecasted Revenue by Application (2025-2030)
5.2.3 Global Pet Veterinary Drug Revenue Market Share by Application (2019-2030)
5.3 Global Pet Veterinary Drug Price by Application
5.3.1 Global Pet Veterinary Drug Price by Application (2019-2024)
5.3.2 Global Pet Veterinary Drug Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Pet Veterinary Drug Market Size by Type
6.1.1 US & Canada Pet Veterinary Drug Sales by Type (2019-2030)
6.1.2 US & Canada Pet Veterinary Drug Revenue by Type (2019-2030)
6.2 US & Canada Pet Veterinary Drug Market Size by Application
6.2.1 US & Canada Pet Veterinary Drug Sales by Application (2019-2030)
6.2.2 US & Canada Pet Veterinary Drug Revenue by Application (2019-2030)
6.3 US & Canada Pet Veterinary Drug Market Size by Country
6.3.1 US & Canada Pet Veterinary Drug Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Pet Veterinary Drug Sales by Country (2019-2030)
6.3.3 US & Canada Pet Veterinary Drug Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pet Veterinary Drug Market Size by Type
7.1.1 Europe Pet Veterinary Drug Sales by Type (2019-2030)
7.1.2 Europe Pet Veterinary Drug Revenue by Type (2019-2030)
7.2 Europe Pet Veterinary Drug Market Size by Application
7.2.1 Europe Pet Veterinary Drug Sales by Application (2019-2030)
7.2.2 Europe Pet Veterinary Drug Revenue by Application (2019-2030)
7.3 Europe Pet Veterinary Drug Market Size by Country
7.3.1 Europe Pet Veterinary Drug Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Pet Veterinary Drug Sales by Country (2019-2030)
7.3.3 Europe Pet Veterinary Drug Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pet Veterinary Drug Market Size
8.1.1 China Pet Veterinary Drug Sales (2019-2030)
8.1.2 China Pet Veterinary Drug Revenue (2019-2030)
8.2 China Pet Veterinary Drug Market Size by Application
8.2.1 China Pet Veterinary Drug Sales by Application (2019-2030)
8.2.2 China Pet Veterinary Drug Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pet Veterinary Drug Market Size by Type
9.1.1 Asia Pet Veterinary Drug Sales by Type (2019-2030)
9.1.2 Asia Pet Veterinary Drug Revenue by Type (2019-2030)
9.2 Asia Pet Veterinary Drug Market Size by Application
9.2.1 Asia Pet Veterinary Drug Sales by Application (2019-2030)
9.2.2 Asia Pet Veterinary Drug Revenue by Application (2019-2030)
9.3 Asia Pet Veterinary Drug Sales by Region
9.3.1 Asia Pet Veterinary Drug Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Pet Veterinary Drug Revenue by Region (2019-2030)
9.3.3 Asia Pet Veterinary Drug Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pet Veterinary Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Pet Veterinary Drug Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Pet Veterinary Drug Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Pet Veterinary Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Pet Veterinary Drug Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Pet Veterinary Drug Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Pet Veterinary Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Pet Veterinary Drug Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Pet Veterinary Drug Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Pet Veterinary Drug Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Boehringer Ingelheim International GmbH
11.1.1 Boehringer Ingelheim International GmbH Company Information
11.1.2 Boehringer Ingelheim International GmbH Overview
11.1.3 Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boehringer Ingelheim International GmbH Recent Developments
11.2 Zoetis Animal Healthcare
11.2.1 Zoetis Animal Healthcare Company Information
11.2.2 Zoetis Animal Healthcare Overview
11.2.3 Zoetis Animal Healthcare Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Zoetis Animal Healthcare Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Zoetis Animal Healthcare Recent Developments
11.3 Bayer AG
11.3.1 Bayer AG Company Information
11.3.2 Bayer AG Overview
11.3.3 Bayer AG Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Bayer AG Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer AG Recent Developments
11.4 Merck Animal Health
11.4.1 Merck Animal Health Company Information
11.4.2 Merck Animal Health Overview
11.4.3 Merck Animal Health Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Merck Animal Health Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Animal Health Recent Developments
11.5 Elanco Animal Health Inc.
11.5.1 Elanco Animal Health Inc. Company Information
11.5.2 Elanco Animal Health Inc. Overview
11.5.3 Elanco Animal Health Inc. Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Elanco Animal Health Inc. Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Elanco Animal Health Inc. Recent Developments
11.6 Virbac Group
11.6.1 Virbac Group Company Information
11.6.2 Virbac Group Overview
11.6.3 Virbac Group Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Virbac Group Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Virbac Group Recent Developments
11.7 Ceva
11.7.1 Ceva Company Information
11.7.2 Ceva Overview
11.7.3 Ceva Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Ceva Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ceva Recent Developments
11.8 Dechra Pharmaceuticals Plc
11.8.1 Dechra Pharmaceuticals Plc Company Information
11.8.2 Dechra Pharmaceuticals Plc Overview
11.8.3 Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dechra Pharmaceuticals Plc Recent Developments
11.9 Vetoquinol
11.9.1 Vetoquinol Company Information
11.9.2 Vetoquinol Overview
11.9.3 Vetoquinol Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Vetoquinol Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Vetoquinol Recent Developments
11.10 Orion Corporation
11.10.1 Orion Corporation Company Information
11.10.2 Orion Corporation Overview
11.10.3 Orion Corporation Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Orion Corporation Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Orion Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pet Veterinary Drug Industry Chain Analysis
12.2 Pet Veterinary Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pet Veterinary Drug Production Mode & Process
12.4 Pet Veterinary Drug Sales and Marketing
12.4.1 Pet Veterinary Drug Sales Channels
12.4.2 Pet Veterinary Drug Distributors
12.5 Pet Veterinary Drug Customers
13 Market Dynamics
13.1 Pet Veterinary Drug Industry Trends
13.2 Pet Veterinary Drug Market Drivers
13.3 Pet Veterinary Drug Market Challenges
13.4 Pet Veterinary Drug Market Restraints
14 Key Findings in The Global Pet Veterinary Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Pet Veterinary Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Anti-Infectives
    Table 3. Major Manufacturers of Anti-Inflammatory
    Table 4. Major Manufacturers of Parasiticides
    Table 5. Major Manufacturers of Analgesics
    Table 6. Major Manufacturers of Sedatives
    Table 7. Major Manufacturers of Others
    Table 8. Global Pet Veterinary Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 9. Global Pet Veterinary Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 10. Global Pet Veterinary Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 11. Global Pet Veterinary Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 12. Global Pet Veterinary Drug Revenue Market Share by Region (2019-2024)
    Table 13. Global Pet Veterinary Drug Revenue Market Share by Region (2025-2030)
    Table 14. Global Pet Veterinary Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 15. Global Pet Veterinary Drug Sales by Region (2019-2024) & (K Units)
    Table 16. Global Pet Veterinary Drug Sales by Region (2025-2030) & (K Units)
    Table 17. Global Pet Veterinary Drug Sales Market Share by Region (2019-2024)
    Table 18. Global Pet Veterinary Drug Sales Market Share by Region (2025-2030)
    Table 19. Global Pet Veterinary Drug Sales by Manufacturers (2019-2024) & (K Units)
    Table 20. Global Pet Veterinary Drug Sales Share by Manufacturers (2019-2024)
    Table 21. Global Pet Veterinary Drug Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 22. Global Pet Veterinary Drug Revenue Share by Manufacturers (2019-2024)
    Table 23. Global Key Players of Pet Veterinary Drug, Industry Ranking, 2022 VS 2023 VS 2024
    Table 24. Pet Veterinary Drug Price by Manufacturers 2019-2024 (USD/Unit)
    Table 25. Global Pet Veterinary Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 26. Global Pet Veterinary Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Veterinary Drug as of 2023)
    Table 27. Global Key Manufacturers of Pet Veterinary Drug, Manufacturing Base Distribution and Headquarters
    Table 28. Global Key Manufacturers of Pet Veterinary Drug, Product Offered and Application
    Table 29. Global Key Manufacturers of Pet Veterinary Drug, Date of Enter into This Industry
    Table 30. Mergers & Acquisitions, Expansion Plans
    Table 31. Global Pet Veterinary Drug Sales by Type (2019-2024) & (K Units)
    Table 32. Global Pet Veterinary Drug Sales by Type (2025-2030) & (K Units)
    Table 33. Global Pet Veterinary Drug Sales Share by Type (2019-2024)
    Table 34. Global Pet Veterinary Drug Sales Share by Type (2025-2030)
    Table 35. Global Pet Veterinary Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 36. Global Pet Veterinary Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 37. Global Pet Veterinary Drug Revenue Share by Type (2019-2024)
    Table 38. Global Pet Veterinary Drug Revenue Share by Type (2025-2030)
    Table 39. Pet Veterinary Drug Price by Type (2019-2024) & (USD/Unit)
    Table 40. Global Pet Veterinary Drug Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 41. Global Pet Veterinary Drug Sales by Application (2019-2024) & (K Units)
    Table 42. Global Pet Veterinary Drug Sales by Application (2025-2030) & (K Units)
    Table 43. Global Pet Veterinary Drug Sales Share by Application (2019-2024)
    Table 44. Global Pet Veterinary Drug Sales Share by Application (2025-2030)
    Table 45. Global Pet Veterinary Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 46. Global Pet Veterinary Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 47. Global Pet Veterinary Drug Revenue Share by Application (2019-2024)
    Table 48. Global Pet Veterinary Drug Revenue Share by Application (2025-2030)
    Table 49. Pet Veterinary Drug Price by Application (2019-2024) & (USD/Unit)
    Table 50. Global Pet Veterinary Drug Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 51. US & Canada Pet Veterinary Drug Sales by Type (2019-2024) & (K Units)
    Table 52. US & Canada Pet Veterinary Drug Sales by Type (2025-2030) & (K Units)
    Table 53. US & Canada Pet Veterinary Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 54. US & Canada Pet Veterinary Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 55. US & Canada Pet Veterinary Drug Sales by Application (2019-2024) & (K Units)
    Table 56. US & Canada Pet Veterinary Drug Sales by Application (2025-2030) & (K Units)
    Table 57. US & Canada Pet Veterinary Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 58. US & Canada Pet Veterinary Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 59. US & Canada Pet Veterinary Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 60. US & Canada Pet Veterinary Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 61. US & Canada Pet Veterinary Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 62. US & Canada Pet Veterinary Drug Sales by Country (2019-2024) & (K Units)
    Table 63. US & Canada Pet Veterinary Drug Sales by Country (2025-2030) & (K Units)
    Table 64. Europe Pet Veterinary Drug Sales by Type (2019-2024) & (K Units)
    Table 65. Europe Pet Veterinary Drug Sales by Type (2025-2030) & (K Units)
    Table 66. Europe Pet Veterinary Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 67. Europe Pet Veterinary Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 68. Europe Pet Veterinary Drug Sales by Application (2019-2024) & (K Units)
    Table 69. Europe Pet Veterinary Drug Sales by Application (2025-2030) & (K Units)
    Table 70. Europe Pet Veterinary Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 71. Europe Pet Veterinary Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 72. Europe Pet Veterinary Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 73. Europe Pet Veterinary Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 74. Europe Pet Veterinary Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 75. Europe Pet Veterinary Drug Sales by Country (2019-2024) & (K Units)
    Table 76. Europe Pet Veterinary Drug Sales by Country (2025-2030) & (K Units)
    Table 77. China Pet Veterinary Drug Sales by Type (2019-2024) & (K Units)
    Table 78. China Pet Veterinary Drug Sales by Type (2025-2030) & (K Units)
    Table 79. China Pet Veterinary Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 80. China Pet Veterinary Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 81. China Pet Veterinary Drug Sales by Application (2019-2024) & (K Units)
    Table 82. China Pet Veterinary Drug Sales by Application (2025-2030) & (K Units)
    Table 83. China Pet Veterinary Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 84. China Pet Veterinary Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 85. Asia Pet Veterinary Drug Sales by Type (2019-2024) & (K Units)
    Table 86. Asia Pet Veterinary Drug Sales by Type (2025-2030) & (K Units)
    Table 87. Asia Pet Veterinary Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 88. Asia Pet Veterinary Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 89. Asia Pet Veterinary Drug Sales by Application (2019-2024) & (K Units)
    Table 90. Asia Pet Veterinary Drug Sales by Application (2025-2030) & (K Units)
    Table 91. Asia Pet Veterinary Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 92. Asia Pet Veterinary Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 93. Asia Pet Veterinary Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 94. Asia Pet Veterinary Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 95. Asia Pet Veterinary Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 96. Asia Pet Veterinary Drug Sales by Region (2019-2024) & (K Units)
    Table 97. Asia Pet Veterinary Drug Sales by Region (2025-2030) & (K Units)
    Table 98. Middle East, Africa and Latin America Pet Veterinary Drug Sales by Type (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Pet Veterinary Drug Sales by Type (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Pet Veterinary Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Pet Veterinary Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Pet Veterinary Drug Sales by Application (2019-2024) & (K Units)
    Table 103. Middle East, Africa and Latin America Pet Veterinary Drug Sales by Application (2025-2030) & (K Units)
    Table 104. Middle East, Africa and Latin America Pet Veterinary Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Pet Veterinary Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Pet Veterinary Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 107. Middle East, Africa and Latin America Pet Veterinary Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 108. Middle East, Africa and Latin America Pet Veterinary Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 109. Middle East, Africa and Latin America Pet Veterinary Drug Sales by Country (2019-2024) & (K Units)
    Table 110. Middle East, Africa and Latin America Pet Veterinary Drug Sales by Country (2025-2030) & (K Units)
    Table 111. Boehringer Ingelheim International GmbH Company Information
    Table 112. Boehringer Ingelheim International GmbH Description and Major Businesses
    Table 113. Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 114. Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Boehringer Ingelheim International GmbH Recent Developments
    Table 116. Zoetis Animal Healthcare Company Information
    Table 117. Zoetis Animal Healthcare Description and Major Businesses
    Table 118. Zoetis Animal Healthcare Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 119. Zoetis Animal Healthcare Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Zoetis Animal Healthcare Recent Developments
    Table 121. Bayer AG Company Information
    Table 122. Bayer AG Description and Major Businesses
    Table 123. Bayer AG Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 124. Bayer AG Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Bayer AG Recent Developments
    Table 126. Merck Animal Health Company Information
    Table 127. Merck Animal Health Description and Major Businesses
    Table 128. Merck Animal Health Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 129. Merck Animal Health Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Merck Animal Health Recent Developments
    Table 131. Elanco Animal Health Inc. Company Information
    Table 132. Elanco Animal Health Inc. Description and Major Businesses
    Table 133. Elanco Animal Health Inc. Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 134. Elanco Animal Health Inc. Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Elanco Animal Health Inc. Recent Developments
    Table 136. Virbac Group Company Information
    Table 137. Virbac Group Description and Major Businesses
    Table 138. Virbac Group Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 139. Virbac Group Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Virbac Group Recent Developments
    Table 141. Ceva Company Information
    Table 142. Ceva Description and Major Businesses
    Table 143. Ceva Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 144. Ceva Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Ceva Recent Developments
    Table 146. Dechra Pharmaceuticals Plc Company Information
    Table 147. Dechra Pharmaceuticals Plc Description and Major Businesses
    Table 148. Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 149. Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Dechra Pharmaceuticals Plc Recent Developments
    Table 151. Vetoquinol Company Information
    Table 152. Vetoquinol Description and Major Businesses
    Table 153. Vetoquinol Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 154. Vetoquinol Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Vetoquinol Recent Developments
    Table 156. Orion Corporation Company Information
    Table 157. Orion Corporation Description and Major Businesses
    Table 158. Orion Corporation Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 159. Orion Corporation Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Orion Corporation Recent Developments
    Table 161. Key Raw Materials Lists
    Table 162. Raw Materials Key Suppliers Lists
    Table 163. Pet Veterinary Drug Distributors List
    Table 164. Pet Veterinary Drug Customers List
    Table 165. Pet Veterinary Drug Market Trends
    Table 166. Pet Veterinary Drug Market Drivers
    Table 167. Pet Veterinary Drug Market Challenges
    Table 168. Pet Veterinary Drug Market Restraints
    Table 169. Research Programs/Design for This Report
    Table 170. Key Data Information from Secondary Sources
    Table 171. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pet Veterinary Drug Product Picture
    Figure 2. Global Pet Veterinary Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Pet Veterinary Drug Market Share by Type in 2023 & 2030
    Figure 4. Anti-Infectives Product Picture
    Figure 5. Anti-Inflammatory Product Picture
    Figure 6. Parasiticides Product Picture
    Figure 7. Analgesics Product Picture
    Figure 8. Sedatives Product Picture
    Figure 9. Others Product Picture
    Figure 10. Global Pet Veterinary Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 11. Global Pet Veterinary Drug Market Share by Application in 2023 & 2030
    Figure 12. Veterinary Hospitals
    Figure 13. Veterinary Clinics
    Figure 14. Drug Stores
    Figure 15. Pet Veterinary Drug Report Years Considered
    Figure 16. Global Pet Veterinary Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Pet Veterinary Drug Revenue 2019-2030 (US$ Million)
    Figure 18. Global Pet Veterinary Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 19. Global Pet Veterinary Drug Revenue Market Share by Region (2019-2030)
    Figure 20. Global Pet Veterinary Drug Sales 2019-2030 ((K Units)
    Figure 21. Global Pet Veterinary Drug Sales Market Share by Region (2019-2030)
    Figure 22. US & Canada Pet Veterinary Drug Sales YoY (2019-2030) & (K Units)
    Figure 23. US & Canada Pet Veterinary Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Pet Veterinary Drug Sales YoY (2019-2030) & (K Units)
    Figure 25. Europe Pet Veterinary Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. China Pet Veterinary Drug Sales YoY (2019-2030) & (K Units)
    Figure 27. China Pet Veterinary Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. Asia (excluding China) Pet Veterinary Drug Sales YoY (2019-2030) & (K Units)
    Figure 29. Asia (excluding China) Pet Veterinary Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. Middle East, Africa and Latin America Pet Veterinary Drug Sales YoY (2019-2030) & (K Units)
    Figure 31. Middle East, Africa and Latin America Pet Veterinary Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 32. The Pet Veterinary Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 33. The Top 5 and 10 Largest Manufacturers of Pet Veterinary Drug in the World: Market Share by Pet Veterinary Drug Revenue in 2023
    Figure 34. Global Pet Veterinary Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 35. Global Pet Veterinary Drug Sales Market Share by Type (2019-2030)
    Figure 36. Global Pet Veterinary Drug Revenue Market Share by Type (2019-2030)
    Figure 37. Global Pet Veterinary Drug Sales Market Share by Application (2019-2030)
    Figure 38. Global Pet Veterinary Drug Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Pet Veterinary Drug Sales Market Share by Type (2019-2030)
    Figure 40. US & Canada Pet Veterinary Drug Revenue Market Share by Type (2019-2030)
    Figure 41. US & Canada Pet Veterinary Drug Sales Market Share by Application (2019-2030)
    Figure 42. US & Canada Pet Veterinary Drug Revenue Market Share by Application (2019-2030)
    Figure 43. US & Canada Pet Veterinary Drug Revenue Share by Country (2019-2030)
    Figure 44. US & Canada Pet Veterinary Drug Sales Share by Country (2019-2030)
    Figure 45. U.S. Pet Veterinary Drug Revenue (2019-2030) & (US$ Million)
    Figure 46. Canada Pet Veterinary Drug Revenue (2019-2030) & (US$ Million)
    Figure 47. Europe Pet Veterinary Drug Sales Market Share by Type (2019-2030)
    Figure 48. Europe Pet Veterinary Drug Revenue Market Share by Type (2019-2030)
    Figure 49. Europe Pet Veterinary Drug Sales Market Share by Application (2019-2030)
    Figure 50. Europe Pet Veterinary Drug Revenue Market Share by Application (2019-2030)
    Figure 51. Europe Pet Veterinary Drug Revenue Share by Country (2019-2030)
    Figure 52. Europe Pet Veterinary Drug Sales Share by Country (2019-2030)
    Figure 53. Germany Pet Veterinary Drug Revenue (2019-2030) & (US$ Million)
    Figure 54. France Pet Veterinary Drug Revenue (2019-2030) & (US$ Million)
    Figure 55. U.K. Pet Veterinary Drug Revenue (2019-2030) & (US$ Million)
    Figure 56. Italy Pet Veterinary Drug Revenue (2019-2030) & (US$ Million)
    Figure 57. Russia Pet Veterinary Drug Revenue (2019-2030) & (US$ Million)
    Figure 58. China Pet Veterinary Drug Sales Market Share by Type (2019-2030)
    Figure 59. China Pet Veterinary Drug Revenue Market Share by Type (2019-2030)
    Figure 60. China Pet Veterinary Drug Sales Market Share by Application (2019-2030)
    Figure 61. China Pet Veterinary Drug Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Pet Veterinary Drug Sales Market Share by Type (2019-2030)
    Figure 63. Asia Pet Veterinary Drug Revenue Market Share by Type (2019-2030)
    Figure 64. Asia Pet Veterinary Drug Sales Market Share by Application (2019-2030)
    Figure 65. Asia Pet Veterinary Drug Revenue Market Share by Application (2019-2030)
    Figure 66. Asia Pet Veterinary Drug Revenue Share by Region (2019-2030)
    Figure 67. Asia Pet Veterinary Drug Sales Share by Region (2019-2030)
    Figure 68. Japan Pet Veterinary Drug Revenue (2019-2030) & (US$ Million)
    Figure 69. South Korea Pet Veterinary Drug Revenue (2019-2030) & (US$ Million)
    Figure 70. China Taiwan Pet Veterinary Drug Revenue (2019-2030) & (US$ Million)
    Figure 71. Southeast Asia Pet Veterinary Drug Revenue (2019-2030) & (US$ Million)
    Figure 72. India Pet Veterinary Drug Revenue (2019-2030) & (US$ Million)
    Figure 73. Middle East, Africa and Latin America Pet Veterinary Drug Sales Market Share by Type (2019-2030)
    Figure 74. Middle East, Africa and Latin America Pet Veterinary Drug Revenue Market Share by Type (2019-2030)
    Figure 75. Middle East, Africa and Latin America Pet Veterinary Drug Sales Market Share by Application (2019-2030)
    Figure 76. Middle East, Africa and Latin America Pet Veterinary Drug Revenue Market Share by Application (2019-2030)
    Figure 77. Middle East, Africa and Latin America Pet Veterinary Drug Revenue Share by Country (2019-2030)
    Figure 78. Middle East, Africa and Latin America Pet Veterinary Drug Sales Share by Country (2019-2030)
    Figure 79. Brazil Pet Veterinary Drug Revenue (2019-2030) & (US$ Million)
    Figure 80. Mexico Pet Veterinary Drug Revenue (2019-2030) & (US$ Million)
    Figure 81. Turkey Pet Veterinary Drug Revenue (2019-2030) & (US$ Million)
    Figure 82. Israel Pet Veterinary Drug Revenue (2019-2030) & (US$ Million)
    Figure 83. GCC Countries Pet Veterinary Drug Revenue (2019-2030) & (US$ Million)
    Figure 84. Pet Veterinary Drug Value Chain
    Figure 85. Pet Veterinary Drug Production Process
    Figure 86. Channels of Distribution
    Figure 87. Distributors Profiles
    Figure 88. Bottom-up and Top-down Approaches for This Report
    Figure 89. Data Triangulation
    Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS